Td/IPV (2025)
UK Health Security Agency · awarded 19 March 2025
Who
| Buyer | UK Health Security Agency London |
|---|---|
| Supplier |
Aventis Pharma ltd t/a Sanofi |
| Category | goods |
| Classification | Vaccines CPV 33651600 |
| Notice published | 11 April 2025 |
What it is for
The provision of low dose diphtheria tetanus and inactivated polio vaccine to be used as part of the national immunisation programme. Deliveries will be required over a period of 3 years, with an option to extend for up to an additional 24 months. Value - The contract value is withheld from publication pursuant to regulation 50(6)(b) of the Public Contracts Regulations 2015 (as amended) so as not to prejudice the legitimate commercial interest of the supplier. The opportunity is not split into lots as the requirement is for a specific vaccine.
Read the original award notice on Contracts Finder →
Other contracts from this buyer
540 awards on file, worth £872.1m.
| Awarded | What for | Buyer | Supplier | Value |
|---|---|---|---|---|
| 1 Jun 2026 | Live Attenuated Influenza vaccine 2026/2027 | UK Health Security Agency | ASTRAZENECA UK LIMITED | £225.4m |
| 18 Jan 2022 | Single Service Centre - HGS | UK Health Security Agency | HINDUJA GLOBAL SOLUTIONS UK LIMITED | £211.9m |
| 3 Dec 2025 | Select Item 1 UKHSA Trust Programme Delivery Partner | UK Health Security Agency | PA CONSULTING SERVICES LIMITED | £29.6m |
| 18 Sep 2024 | Enterprise Data Platform Delivery partner | UK Health Security Agency | KAINOS SOFTWARE LIMITED | £18.0m |
| 18 Sep 2024 | Enterprise Data Platform Delivery partner | UK Health Security Agency | KAINOS SOFTWARE LIMITED | £18.0m |
Everything UK Health Security Agency has awarded →
Other contracts won by this supplier
4 awards on file, worth £1.9bn.
| Awarded | What for | Buyer | Supplier | Value |
|---|---|---|---|---|
| 24 Mar 2025 | NHS Framework Agreement for Branded Medicines - Proprietary Category TenderEast Midlands | NHS England | CSL Behring UK Ltd +71 | £1.2bn |
| 22 Jul 2024 | NHS Branded Medicines Tranche Framework for London and South of EnglandEast Midlands | NHS England | Sun Pharma UK Ltd +28 | £381.0m |
| 25 Jun 2025 | NHS Branded Medicines Tranche A - London & SOFE & Adult Influenza National | NHS England | Roche Products Ltd +27 | £261.9m |
| 19 Mar 2025 | Td/IPV (2025) | UK Health Security Agency | Aventis Pharma ltd t/a Sanofi | £1 |